Chemokine receptor antagonist and medical use thereof
The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound represented by formula (I) has chemokine recept...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HABASHITA HIROMU SHIBAYAMA SHIRO KOMIYA TAKAKI TAKEDA KAZUHIKO WATANABE NORIKI TOKUDA NATSUKO OCHIAI HIROSHI |
| description | The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound represented by formula (I) has chemokine receptor (especially in CCR4 and/or CCR5) antagonistic activity. Therefore it is useful for prevention and/or treatment of a chemokine receptor-mediated disease such as inflammatory and/or allergic diseases [systemic inflammatory response syndrome (SIRS), anaphylaxis, anaphylactoid reaction, allergic angiitis, transplant rejection reaction, hepatitis, nephritis, nephropathy, pancreatitis, rhinitis, arthritis, inflammatory ocular disease, inflammatory bowel disease, disease in cerebro and/or circulatory system, respiratory disease, dermatosis, autoimmune disease, and the like], infection [viral disease (human immunodeficiency virus infection, acquired immunodeficiency syndrome, SARS, etc.), and the like], and the like. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7732442B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7732442B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7732442B23</originalsourceid><addsrcrecordid>eNrjZDB1zkjNzc_OzEtVKEpNTi0oyS9SSMwrSUzPz8ssLgEyUxRyU1MykxNzFEqLUxVKMlKLUvPTeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJfGiwubmxkYmJkZORMRFKACaWLRM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chemokine receptor antagonist and medical use thereof</title><source>esp@cenet</source><creator>HABASHITA HIROMU ; SHIBAYAMA SHIRO ; KOMIYA TAKAKI ; TAKEDA KAZUHIKO ; WATANABE NORIKI ; TOKUDA NATSUKO ; OCHIAI HIROSHI</creator><creatorcontrib>HABASHITA HIROMU ; SHIBAYAMA SHIRO ; KOMIYA TAKAKI ; TAKEDA KAZUHIKO ; WATANABE NORIKI ; TOKUDA NATSUKO ; OCHIAI HIROSHI</creatorcontrib><description>The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound represented by formula (I) has chemokine receptor (especially in CCR4 and/or CCR5) antagonistic activity. Therefore it is useful for prevention and/or treatment of a chemokine receptor-mediated disease such as inflammatory and/or allergic diseases [systemic inflammatory response syndrome (SIRS), anaphylaxis, anaphylactoid reaction, allergic angiitis, transplant rejection reaction, hepatitis, nephritis, nephropathy, pancreatitis, rhinitis, arthritis, inflammatory ocular disease, inflammatory bowel disease, disease in cerebro and/or circulatory system, respiratory disease, dermatosis, autoimmune disease, and the like], infection [viral disease (human immunodeficiency virus infection, acquired immunodeficiency syndrome, SARS, etc.), and the like], and the like.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100608&DB=EPODOC&CC=US&NR=7732442B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100608&DB=EPODOC&CC=US&NR=7732442B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HABASHITA HIROMU</creatorcontrib><creatorcontrib>SHIBAYAMA SHIRO</creatorcontrib><creatorcontrib>KOMIYA TAKAKI</creatorcontrib><creatorcontrib>TAKEDA KAZUHIKO</creatorcontrib><creatorcontrib>WATANABE NORIKI</creatorcontrib><creatorcontrib>TOKUDA NATSUKO</creatorcontrib><creatorcontrib>OCHIAI HIROSHI</creatorcontrib><title>Chemokine receptor antagonist and medical use thereof</title><description>The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound represented by formula (I) has chemokine receptor (especially in CCR4 and/or CCR5) antagonistic activity. Therefore it is useful for prevention and/or treatment of a chemokine receptor-mediated disease such as inflammatory and/or allergic diseases [systemic inflammatory response syndrome (SIRS), anaphylaxis, anaphylactoid reaction, allergic angiitis, transplant rejection reaction, hepatitis, nephritis, nephropathy, pancreatitis, rhinitis, arthritis, inflammatory ocular disease, inflammatory bowel disease, disease in cerebro and/or circulatory system, respiratory disease, dermatosis, autoimmune disease, and the like], infection [viral disease (human immunodeficiency virus infection, acquired immunodeficiency syndrome, SARS, etc.), and the like], and the like.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1zkjNzc_OzEtVKEpNTi0oyS9SSMwrSUzPz8ssLgEyUxRyU1MykxNzFEqLUxVKMlKLUvPTeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJfGiwubmxkYmJkZORMRFKACaWLRM</recordid><startdate>20100608</startdate><enddate>20100608</enddate><creator>HABASHITA HIROMU</creator><creator>SHIBAYAMA SHIRO</creator><creator>KOMIYA TAKAKI</creator><creator>TAKEDA KAZUHIKO</creator><creator>WATANABE NORIKI</creator><creator>TOKUDA NATSUKO</creator><creator>OCHIAI HIROSHI</creator><scope>EVB</scope></search><sort><creationdate>20100608</creationdate><title>Chemokine receptor antagonist and medical use thereof</title><author>HABASHITA HIROMU ; SHIBAYAMA SHIRO ; KOMIYA TAKAKI ; TAKEDA KAZUHIKO ; WATANABE NORIKI ; TOKUDA NATSUKO ; OCHIAI HIROSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7732442B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HABASHITA HIROMU</creatorcontrib><creatorcontrib>SHIBAYAMA SHIRO</creatorcontrib><creatorcontrib>KOMIYA TAKAKI</creatorcontrib><creatorcontrib>TAKEDA KAZUHIKO</creatorcontrib><creatorcontrib>WATANABE NORIKI</creatorcontrib><creatorcontrib>TOKUDA NATSUKO</creatorcontrib><creatorcontrib>OCHIAI HIROSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HABASHITA HIROMU</au><au>SHIBAYAMA SHIRO</au><au>KOMIYA TAKAKI</au><au>TAKEDA KAZUHIKO</au><au>WATANABE NORIKI</au><au>TOKUDA NATSUKO</au><au>OCHIAI HIROSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chemokine receptor antagonist and medical use thereof</title><date>2010-06-08</date><risdate>2010</risdate><abstract>The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound represented by formula (I) has chemokine receptor (especially in CCR4 and/or CCR5) antagonistic activity. Therefore it is useful for prevention and/or treatment of a chemokine receptor-mediated disease such as inflammatory and/or allergic diseases [systemic inflammatory response syndrome (SIRS), anaphylaxis, anaphylactoid reaction, allergic angiitis, transplant rejection reaction, hepatitis, nephritis, nephropathy, pancreatitis, rhinitis, arthritis, inflammatory ocular disease, inflammatory bowel disease, disease in cerebro and/or circulatory system, respiratory disease, dermatosis, autoimmune disease, and the like], infection [viral disease (human immunodeficiency virus infection, acquired immunodeficiency syndrome, SARS, etc.), and the like], and the like.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US7732442B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Chemokine receptor antagonist and medical use thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HABASHITA%20HIROMU&rft.date=2010-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7732442B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |